188 related articles for article (PubMed ID: 15085023)
21. [Measurement of fecal elastase 1 by immunoreactivity: a new indirect test of the pancreatic function].
Stein J; Schoonbroodt D; Jung M; Lembcke B; Caspary WF
Gastroenterol Clin Biol; 1996; 20(5):424-9. PubMed ID: 8761139
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis.
Vanga RR; Tansel A; Sidiq S; El-Serag HB; Othman MO
Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1220-1228.e4. PubMed ID: 29374614
[TBL] [Abstract][Full Text] [Related]
23. How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease?
Beharry S; Ellis L; Corey M; Marcon M; Durie P
J Pediatr; 2002 Jul; 141(1):84-90. PubMed ID: 12091856
[TBL] [Abstract][Full Text] [Related]
24. Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test.
Löser C; Möllgaard A; Fölsch UR
Gut; 1996 Oct; 39(4):580-6. PubMed ID: 8944569
[TBL] [Abstract][Full Text] [Related]
25. Fecal elastase-1 is decreased in villous atrophy regardless of the underlying disease.
Walkowiak J; Herzig KH
Eur J Clin Invest; 2001 May; 31(5):425-30. PubMed ID: 11380594
[TBL] [Abstract][Full Text] [Related]
26. Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis.
Borowitz D; Baker SS; Duffy L; Baker RD; Fitzpatrick L; Gyamfi J; Jarembek K
J Pediatr; 2004 Sep; 145(3):322-6. PubMed ID: 15343184
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic Elastase-1 Quick Test for rapid assessment of pancreatic status in cystic fibrosis patients.
Walkowiak J; Glapa A; Nowak JK; Bober L; Rohovyk N; Wenska-Chyży E; Sobkowiak P; Lisowska A
J Cyst Fibros; 2016 Sep; 15(5):664-8. PubMed ID: 27287722
[TBL] [Abstract][Full Text] [Related]
28. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype.
Augarten A; Ben Tov A; Madgar I; Barak A; Akons H; Laufer J; Efrati O; Aviram M; Bentur L; Blau H; Paret G; Wilschanski M; Kerem BS; Yahav Y
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):164-8. PubMed ID: 18301294
[TBL] [Abstract][Full Text] [Related]
29. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
Dorlöchter L; Aksnes L; Fluge G
Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
[TBL] [Abstract][Full Text] [Related]
30. 13C-Mixed Triglyceride Breath Test and Fecal Elastase as an Indirect Pancreatic Function Test in Cystic Fibrosis Infants.
Kent DS; Remer T; Blumenthal C; Hunt S; Simonds S; Egert S; Gaskin KJ
J Pediatr Gastroenterol Nutr; 2018 May; 66(5):811-815. PubMed ID: 29432279
[TBL] [Abstract][Full Text] [Related]
31. Indirect parameters of pancreatic function in cystic fibrosis (CF) during a controlled double-blind trial of pancreatic supplementation.
Regele S; Henker J; Münch R; Barbier Y; Stern M
J Pediatr Gastroenterol Nutr; 1996 Jan; 22(1):68-72. PubMed ID: 8788290
[TBL] [Abstract][Full Text] [Related]
32. Lingual lipase in cystic fibrosis. Quantitation of enzyme activity in the upper small intestine of patients with exocrine pancreatic insufficiency.
Abrams CK; Hamosh M; Hubbard VS; Dutta SK; Hamosh P
J Clin Invest; 1984 Feb; 73(2):374-82. PubMed ID: 6699170
[TBL] [Abstract][Full Text] [Related]
33. Low fecal elastase: potentially related to transient small bowel damage resulting from enteric pathogens.
Salvatore S; Finazzi S; Barassi A; Verzelletti M; Tosi A; Melzi d'Eril GV; Nespoli L
J Pediatr Gastroenterol Nutr; 2003 Mar; 36(3):392-6. PubMed ID: 12604981
[TBL] [Abstract][Full Text] [Related]
34. Detection and follow up of exocrine pancreatic insufficiency in cystic fibrosis: a review.
Leus J; Van Biervliet S; Robberecht E
Eur J Pediatr; 2000 Aug; 159(8):563-8. PubMed ID: 10968231
[TBL] [Abstract][Full Text] [Related]
35. Comparison of fecal elastase-1 and pancreatic function testing in children.
Wali PD; Loveridge-Lenza B; He Z; Horvath K
J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):277-80. PubMed ID: 22266489
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic accuracy of secretin-stimulated ultrasonography of the pancreas assessing exocrine pancreatic failure in cystic fibrosis and chronic pancreatitis.
Engjom T; Erchinger F; Tjora E; Lærum BN; Georg D; Gilja OH
Scand J Gastroenterol; 2015 May; 50(5):601-10. PubMed ID: 25623422
[TBL] [Abstract][Full Text] [Related]
37. Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations.
Walkowiak J; Sands D; Nowakowska A; Piotrowski R; Zybert K; Herzig KH; Milanowski A
J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):199-201. PubMed ID: 15699697
[TBL] [Abstract][Full Text] [Related]
38. Comparison of monoclonal and polyclonal ELISAs for fecal elastase in patients with cystic fibrosis and pancreatic insufficiency.
Borowitz D; Lin R; Baker SS
J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):219-23. PubMed ID: 17255835
[TBL] [Abstract][Full Text] [Related]
39. Secretin-Stimulated Magnetic Resonance Imaging Reveals Variable Diagnostic Accuracy According to Etiology in Pancreatic Disease.
Engjom T; Tjora E; Erchinger F; Madzak A; Dimcevski G; Frøkjær JB; Haldorsen IS
Pancreas; 2020 Mar; 49(3):361-367. PubMed ID: 32132505
[TBL] [Abstract][Full Text] [Related]
40. Serum lipase levels as a diagnostic marker in cystic fibrosis patients with normal or borderline sweat tests.
Augarten A; Shmilovich H; Doolman R; Aviram M; Akons H; Ben Tur L; Blau H; Kerem E; Rivlin J; Sela BA; Szeinberg A; Yahav Y
Pediatr Pulmonol; 2000 Oct; 30(4):320-3. PubMed ID: 11015133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
